Exchange Traded Concepts, LLC Abb Vie Inc. Transaction History

Exchange Traded Concepts, LLC

$4.18 Billion
Q3 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 20,883 shares of ABBV stock, worth $3.66 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

20,883

Previous 117,565 82.24%

Holding current value

$3.66 Million

Previous $20.2 Million 79.55%

% of portfolio

0.1%

Previous 0.52%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$163.84 - $199.33 $15.8 Million - $19.3 Million	-96,682 Reduced 82.24%	20,883 $4.12 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $3.3 Million - $3.85 Million	21,324 Added 22.16%	117,565 $20.2 Million
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $10 Million - $11.4 Million	-62,635 Reduced 39.42%	96,241 $17.5 Million
Q4 2023 Jan 05, 2024	BUY	$137.6 - $154.97 $1.52 Million - $1.71 Million	11,039 Added 7.47%	158,876 $24.6 Million
Q3 2023 Oct 18, 2023	BUY	$133.59 - $154.65 $2.99 Million - $3.46 Million	22,346 Added 17.81%	147,837 $22 Million
Q2 2023 Jul 20, 2023	BUY	$132.51 - $164.9 $4.49 Million - $5.58 Million	33,863 Added 36.96%	125,491 $16.9 Million
Q1 2023 Apr 12, 2023	SELL	$144.61 - $166.54 $4.91 Million - $5.65 Million	-33,935 Reduced 27.03%	91,628 $14.6 Million
Q4 2022 Jan 17, 2023	SELL	$138.31 - $165.87 $472,881 - $567,109	-3,419 Reduced 2.65%	125,563 $20.3 Million
Q3 2022 Oct 07, 2022	BUY	$134.21 - $153.93 $545,697 - $625,879	4,066 Added 3.25%	128,982 $17.3 Million
Q2 2022 Jul 20, 2022	BUY	$137.62 - $174.96 $11.3 Million - $14.3 Million	81,947 Added 190.71%	124,916 $19.1 Million
Q1 2022 Apr 26, 2022	SELL	$131.98 - $163.75 $7.28 Million - $9.03 Million	-55,128 Reduced 56.2%	42,969 $6.97 Million
Q4 2021 Jan 13, 2022	BUY	$107.43 - $135.93 $4.68 Million - $5.92 Million	43,588 Added 79.96%	98,097 $13.3 Million
Q3 2021 Oct 18, 2021	SELL	$106.4 - $120.78 $9.14 Million - $10.4 Million	-85,895 Reduced 61.18%	54,509 $5.88 Million
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $5.6 Million - $6.24 Million	53,257 Added 61.11%	140,404 $15.8 Million
Q1 2021 Apr 20, 2021	SELL	$102.3 - $112.62 $68,131 - $75,004	-666 Reduced 0.76%	87,147 $9.43 Million
Q4 2020 Jan 19, 2021	SELL	$80.49 - $108.67 $2.53 Million - $3.41 Million	-31,408 Reduced 26.34%	87,813 $9.41 Million
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $6.52 Million - $7.66 Million	75,950 Added 175.52%	119,221 $10.4 Million
Q2 2020 Jul 15, 2020	BUY	$73.37 - $98.18 $3.09 Million - $4.13 Million	42,100 Added 3595.22%	43,271 $4.25 Million
Q1 2020 Apr 14, 2020	BUY	$64.5 - $97.79 $69,337 - $105,124	1,075 Added 1119.79%	1,171 $89,000
Q4 2019 Jan 22, 2020	BUY	$72.13 - $90.25 $6,924 - $8,664	96 New	96 $8,000

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Abb Vie Inc. Transaction History